El-Dada Riad Hussein 4

What Happened
El‑Dada Riad Hussein, a director of Klotho Neurosciences, received an award of 350,000 shares on 2026-03-04. The Form 4 reports this as an "A" (award/grant) transaction; no purchase price or aggregate dollar value is shown on the filing, indicating the shares were issued as compensation under the company’s Equity Incentive Plan.

Key Details

• Transaction date: 2026-03-04; Form 4 filed: 2026-03-06. The filing appears timely.
• Transaction type/code: A (Grant/Award).
• Shares received: 350,000. Price per share: N/A (grant — no cash purchase). Aggregate value: not disclosed on the form.
• Footnote: F1 — shares were granted under the company’s Equity Incentive Plan.
• Shares owned after transaction: not specified in the provided filing excerpt.
• No indication in the filing that shares were immediately sold or part of a 10b5-1 plan.

Context
Equity grants to directors are common as compensation and may be subject to vesting schedules, transfer restrictions, or holding requirements; the Form 4 does not detail vesting or restrictions beyond the Equity Incentive Plan reference. Such awards are compensatory and do not necessarily signal the director’s view of the stock’s near‑term prospects.